JP2003509038A5 - - Google Patents

Download PDF

Info

Publication number
JP2003509038A5
JP2003509038A5 JP2001523619A JP2001523619A JP2003509038A5 JP 2003509038 A5 JP2003509038 A5 JP 2003509038A5 JP 2001523619 A JP2001523619 A JP 2001523619A JP 2001523619 A JP2001523619 A JP 2001523619A JP 2003509038 A5 JP2003509038 A5 JP 2003509038A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001523619A
Other versions
JP2003509038A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/025558 external-priority patent/WO2001019842A1/en
Publication of JP2003509038A publication Critical patent/JP2003509038A/ja
Publication of JP2003509038A5 publication Critical patent/JP2003509038A5/ja
Pending legal-status Critical Current

Links

JP2001523619A 1999-09-17 2000-09-18 サブユニット最適化された融合タンパク質 Pending JP2003509038A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39907999A 1999-09-17 1999-09-17
US09/399,079 1999-09-17
PCT/US2000/025558 WO2001019842A1 (en) 1999-09-17 2000-09-18 Subunit optimized fusion proteins

Publications (2)

Publication Number Publication Date
JP2003509038A JP2003509038A (ja) 2003-03-11
JP2003509038A5 true JP2003509038A5 (ja) 2005-11-17

Family

ID=23578058

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001523619A Pending JP2003509038A (ja) 1999-09-17 2000-09-18 サブユニット最適化された融合タンパク質

Country Status (14)

Country Link
EP (1) EP1237900A4 (ja)
JP (1) JP2003509038A (ja)
KR (1) KR20020039346A (ja)
CN (1) CN1379782A (ja)
AU (1) AU781462B2 (ja)
BR (1) BR0014524A (ja)
CA (1) CA2384766A1 (ja)
HU (1) HUP0202702A2 (ja)
IL (1) IL148549A0 (ja)
MX (1) MXPA02002768A (ja)
NO (1) NO20021244L (ja)
NZ (1) NZ517774A (ja)
RU (1) RU2002110116A (ja)
WO (1) WO2001019842A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030035798A1 (en) 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
EP1578917A4 (en) 2001-07-19 2008-01-23 Perlan Therapeutics Inc MULTIMEDIA PROTEINS AND METHODS FOR THE PRODUCTION AND USE THEREOF
WO2015077071A1 (en) * 2013-11-19 2015-05-28 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized b-cell activating factor gene

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111748A0 (en) * 1993-12-03 1995-01-24 Zeneca Ltd Proteins
GB9406974D0 (en) * 1994-04-08 1994-06-01 Pharmaceutical Proteins Ltd Transgenic production
US5959171A (en) * 1994-08-17 1999-09-28 Pharming B.V. Method for the production of biologically active polypeptides in a mammal's
US5635363A (en) * 1995-02-28 1997-06-03 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
AU6184298A (en) * 1997-02-25 1998-09-09 Genzyme Transgenics Corporation Transgenically produced non-secreted proteins
GB9708918D0 (en) * 1997-05-01 1997-06-25 Ppl Therapeutics Scotland Ltd Methods
EP1088084B1 (en) * 1998-06-15 2006-09-13 GTC Biotherapeutics, Inc. Erythropoietin analog-human serum albumin fusion protein

Similar Documents

Publication Publication Date Title
BE2014C035I2 (ja)
BE2014C009I2 (ja)
BE2011C041I2 (ja)
BE2010C019I2 (ja)
BRPI0112928B8 (ja)
JP2003521840A5 (ja)
JP2001258013A5 (ja)
JP2001224865A5 (ja)
JP2002048399A5 (ja)
JP2001226877A5 (ja)
JP2001325296A5 (ja)
JP2002057196A5 (ja)
JP2002542545A5 (ja)
CH694022C1 (ja)
JP2002021309A5 (ja)
JP2003509038A5 (ja)
JP2002127699A5 (ja)
JP2002151988A5 (ja)
BRPI0000763B8 (ja)
BR122012015772A2 (ja)
CN3141017S (ja)
CN3142478S (ja)
CN3141399S (ja)
CN3141398S (ja)
BY6855C1 (ja)